$KVA, KVB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in K-V Pharmaceutical Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in K-V Pharmaceutical Co. Get notifications about new insider transactions in K-V Pharmaceutical Co for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 23 2009 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Director | Buy | W | 0.00 | 18,631 | 0 | 1,452,439 | 1.4 M to 1.5 M (+1.30 %) |
Apr 29 2009 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Interim Pres./ Inte ... | Option Exercise | A | 1.52 | 50,000 | 76,000 | 50,000 | |
Apr 29 2009 | KVA, KVB | K-V Pharmaceutical ... | DIVIS GREG J | President, Ther-Rx ... | Option Exercise | A | 1.52 | 10,000 | 15,200 | 10,000 | |
Apr 29 2009 | KVA, KVB | K-V Pharmaceutical ... | Brady Paul T | President, PDI | Option Exercise | A | 1.52 | 10,000 | 15,200 | 10,000 | |
Feb 02 2009 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Director | Sell | J | 0.00 | 2,234,145 | 0 | 0 | 2.2 M to 0 (-100.00 %) |
Feb 02 2009 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Director | Sell | J | 0.00 | 794,248 | 0 | 0 | 794.2 K to 0 (-100.00 %) |
Jan 23 2009 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Director | Sell | J | 0.00 | 48,138 | 0 | 1,000,312 | 1 M to 1 M (-4.59 %) |
Jan 23 2009 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Director | Sell | J | 0.00 | 106,667 | 0 | 794,248 | 900.9 K to 794.2 K (-11.84 %) |
Jan 23 2009 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Director | Sell | J | 0.00 | 131,885 | 0 | 900,915 | 1 M to 900.9 K (-12.77 %) |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | Brady Paul T | President, PDI | Option Exercise | A | 28.60 | 10,000 | 286,000 | 10,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | Brady Paul T | President, PDI | Option Exercise | A | 2.95 | 40,000 | 118,000 | 40,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | BELLIN JEAN M | Director | Option Exercise | A | 2.95 | 15,000 | 44,250 | 15,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | Hermelin David S | Vice President | Option Exercise | A | 2.95 | 15,000 | 44,250 | 15,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | A | 2.95 | 15,000 | 44,250 | 15,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | Hatfield Terry B | Director | Option Exercise | A | 2.95 | 15,000 | 44,250 | 15,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | CEO, ETHEX Corporat ... | Option Exercise | A | 2.95 | 70,000 | 206,500 | 70,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | Killmer Jonathon E | Director | Option Exercise | A | 2.95 | 15,000 | 44,250 | 15,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Option Exercise | A | 2.95 | 15,000 | 44,250 | 15,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | BLESER RITA | Pres. - Pharmaceuti ... | Option Exercise | A | 2.95 | 50,000 | 147,500 | 50,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | KANTERMAN RONALD J | VP, CFO & Treasurer | Option Exercise | A | 2.95 | 50,000 | 147,500 | 50,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Option Exercise | A | 2.95 | 15,000 | 44,250 | 15,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Interim Pres./ Inte ... | Option Exercise | A | 2.95 | 150,000 | 442,500 | 150,000 | |
Jan 15 2009 | KVA, KVB | K-V Pharmaceutical ... | DIVIS GREG J | President, Ther-Rx ... | Option Exercise | A | 2.95 | 70,000 | 206,500 | 70,000 | |
Oct 03 2008 | KVA, KVB | K-V Pharmaceutical ... | BELLIN JEAN M | Director | Option Exercise | A | 22.32 | 4,500 | 100,440 | 4,500 | |
Nov 25 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 45,671 | 0 | 1,032,800 | 1.1 M to 1 M (-4.23 %) |
Nov 14 2008 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Sell | S | 5.00 | 28,000 | 140,042 | 4,350 | 32.4 K to 4.4 K (-86.55 %) |
Oct 03 2008 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | A | 22.32 | 4,500 | 100,440 | 4,500 | |
Oct 03 2008 | KVA, KVB | K-V Pharmaceutical ... | Killmer Jonathon E | Director | Option Exercise | A | 22.32 | 4,500 | 100,440 | 4,500 | |
Oct 03 2008 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Option Exercise | A | 22.32 | 4,500 | 100,440 | 4,500 | |
Oct 03 2008 | KVA, KVB | K-V Pharmaceutical ... | Hatfield Terry B | Director | Option Exercise | A | 22.32 | 4,500 | 100,440 | 4,500 | |
Sep 22 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 186,863 | 0 | 1,503,406 | 1.3 M to 1.5 M (+14.19 %) |
Sep 22 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 186,863 | 0 | 365,262 | 552.1 K to 365.3 K (-33.84 %) |
Sep 22 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 46,800 | 0 | 165,547 | 118.7 K to 165.5 K (+39.41 %) |
Sep 22 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 46,800 | 0 | 491,499 | 538.3 K to 491.5 K (-8.69 %) |
Sep 22 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 233,663 | 0 | 538,299 | 772 K to 538.3 K (-30.27 %) |
Sep 05 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 70 | 0 | 1,316,543 | 1.3 M to 1.3 M (-0.01 %) |
Sep 05 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 70 | 0 | 118,747 | 118.7 K to 118.7 K (+0.06 %) |
Sep 05 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 30,500 | 0 | 2,246,209 | 2.2 M to 2.2 M (+1.38 %) |
Sep 05 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 30,500 | 0 | 1,048,450 | 1.1 M to 1 M (-2.83 %) |
Sep 05 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 23,500 | 0 | 2,234,145 | 2.2 M to 2.2 M (+1.06 %) |
Sep 05 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 23,500 | 0 | 1,078,471 | 1.1 M to 1.1 M (-2.13 %) |
Sep 05 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 23,500 | 0 | 1,771,293 | 1.7 M to 1.8 M (+1.34 %) |
Sep 05 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 23,500 | 0 | 956,036 | 979.5 K to 956 K (-2.40 %) |
Sep 05 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 70,500 | 0 | 552,125 | 622.6 K to 552.1 K (-11.32 %) |
Sep 05 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 70,500 | 0 | 771,962 | 701.5 K to 772 K (+10.05 %) |
Jul 21 2008 | KVA, KVB | K-V Pharmaceutical ... | DIVIS GREG J | President, Ther-Rx ... | Option Exercise | M | 28.60 | 1,225 | 35,035 | 28,775 | |
Jul 21 2008 | KVA, KVB | K-V Pharmaceutical ... | DIVIS GREG J | President, Ther-Rx ... | Buy | M | 28.60 | 1,225 | 35,035 | 1,225 | 0 to 1.2 K |
Jul 18 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 133,334 | 0 | 2,215,709 | 2.1 M to 2.2 M (+6.40 %) |
Jul 18 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 133,334 | 0 | 1,078,950 | 1.2 M to 1.1 M (-11.00 %) |
Jul 18 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 133,333 | 0 | 2,210,645 | 2.1 M to 2.2 M (+6.42 %) |
Jul 18 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 133,333 | 0 | 1,101,971 | 1.2 M to 1.1 M (-10.79 %) |
Jul 18 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 133,333 | 0 | 1,747,793 | 1.6 M to 1.7 M (+8.26 %) |
Jul 18 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 133,333 | 0 | 979,536 | 1.1 M to 979.5 K (-11.98 %) |
Jul 18 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 400,000 | 0 | 622,625 | 1 M to 622.6 K (-39.12 %) |
Jul 18 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 400,000 | 0 | 701,462 | 301.5 K to 701.5 K (+132.69 %) |
Jun 27 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 233,663 | 0 | 301,462 | 535.1 K to 301.5 K (-43.67 %) |
Apr 02 2008 | KVA, KVB | K-V Pharmaceutical ... | Killmer Jonathon E | Director | Option Exercise | A | 25.12 | 2,500 | 62,800 | 2,500 | |
Apr 02 2008 | KVA, KVB | K-V Pharmaceutical ... | KANTERMAN RONALD J | Vice President & Tr ... | Option Exercise | A | 24.96 | 25,000 | 624,000 | 25,000 | |
Apr 01 2008 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | M | 19.37 | 450 | 8,717 | 0 | |
Apr 01 2008 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Buy | M | 19.37 | 450 | 8,717 | 13,500 | 13.1 K to 13.5 K (+3.45 %) |
Jan 25 2008 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 35,256 | 0 | 1,235,304 | 1.3 M to 1.2 M (-2.77 %) |
Jan 07 2008 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Gift | G | 0.00 | 2,640 | 0 | 32,490 | 35.1 K to 32.5 K (-7.51 %) |
Dec 28 2007 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 208,696 | 0 | 1,647,994 | 1.9 M to 1.6 M (-11.24 %) |
Dec 18 2007 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Chief Administratio ... | Option Exercise | M | 23.70 | 1,500 | 35,550 | 0 | |
Dec 18 2007 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Chief Administratio ... | Buy | M | 23.70 | 1,500 | 35,550 | 1,500 | 0 to 1.5 K |
Dec 28 2007 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Gift | G | 0.00 | 2,475 | 0 | 35,130 | 37.6 K to 35.1 K (-6.58 %) |
Dec 14 2007 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Gift | G | 0.00 | 28,269 | 0 | 118,677 | 146.9 K to 118.7 K (-19.24 %) |
Dec 14 2007 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 28,269 | 0 | 146,946 | 118.7 K to 146.9 K (+23.82 %) |
Nov 05 2007 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | D | 30.78 | 45,531 | 1,401,444 | 118,677 | 164.2 K to 118.7 K (-27.73 %) |
Nov 05 2007 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 45,531 | 0 | 164,208 | 118.7 K to 164.2 K (+38.37 %) |
Oct 19 2007 | KVA, KVB | K-V Pharmaceutical ... | BELLIN JEAN M | Director | Option Exercise | A | 19.99 | 2,500 | 49,975 | 2,500 | |
Oct 19 2007 | KVA, KVB | K-V Pharmaceutical ... | BELLIN JEAN M | Director | Option Exercise | D | 16.79 | 2,500 | 41,975 | 0 | |
Oct 19 2007 | KVA, KVB | K-V Pharmaceutical ... | BELLIN JEAN M | Director | Option Exercise | A | 18.42 | 2,500 | 46,050 | 2,500 | |
Oct 19 2007 | KVA, KVB | K-V Pharmaceutical ... | BELLIN JEAN M | Director | Option Exercise | D | 17.85 | 2,500 | 44,625 | 0 | |
Oct 19 2007 | KVA, KVB | K-V Pharmaceutical ... | BELLIN JEAN M | Director | Option Exercise | A | 18.87 | 7,500 | 141,525 | 7,500 | |
Oct 19 2007 | KVA, KVB | K-V Pharmaceutical ... | BELLIN JEAN M | Director | Option Exercise | D | 16.59 | 7,500 | 124,410 | 0 | |
Oct 18 2007 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 37,500 | 0 | 1,270,560 | 1.3 M to 1.3 M (-2.87 %) |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | Hatfield Terry B | Director | Option Exercise | A | 19.26 | 2,500 | 48,150 | 2,500 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | Hatfield Terry B | Director | Option Exercise | D | 16.79 | 2,500 | 41,975 | 0 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | Hatfield Terry B | Director | Option Exercise | A | 18.42 | 2,500 | 46,050 | 2,500 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | Hatfield Terry B | Director | Option Exercise | D | 17.85 | 2,500 | 44,625 | 0 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | Hatfield Terry B | Director | Option Exercise | A | 25.25 | 5,000 | 126,250 | 5,000 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | Hatfield Terry B | Director | Option Exercise | D | 25.23 | 5,000 | 126,150 | 0 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Option Exercise | A | 19.99 | 10,000 | 199,900 | 10,000 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Option Exercise | D | 16.79 | 10,000 | 167,900 | 0 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | KANTERMAN RONALD J | Vice President & T ... | Option Exercise | A | 24.56 | 2,500 | 61,400 | 25,000 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | KANTERMAN RONALD J | Vice President & T ... | Option Exercise | D | 23.90 | 2,500 | 59,750 | 22,500 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | KANTERMAN RONALD J | Vice President & T ... | Option Exercise | A | 24.56 | 22,500 | 552,600 | 25,000 | |
Oct 16 2007 | KVA, KVB | K-V Pharmaceutical ... | KANTERMAN RONALD J | Vice President & T ... | Option Exercise | D | 23.90 | 22,500 | 537,750 | 2,500 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | A | 19.99 | 25,000 | 499,750 | 25,000 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | D | 16.79 | 25,000 | 419,750 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | A | 23.09 | 1,000 | 23,090 | 1,000 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | D | 22.25 | 1,000 | 22,250 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | A | 23.09 | 9,000 | 207,810 | 9,000 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | D | 22.25 | 9,000 | 200,250 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | A | 4.89 | 3,375 | 16,504 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | D | 3.45 | 3,375 | 11,644 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | Corp. VP-Indus Pres ... | Option Exercise | A | 23.09 | 500 | 11,545 | 5,000 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | Corp. VP-Indus Pres ... | Option Exercise | D | 22.25 | 500 | 11,125 | 4,500 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | Corp. VP-Indus Pres ... | Option Exercise | A | 23.09 | 4,500 | 103,905 | 5,000 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | Corp. VP-Indus Pres ... | Option Exercise | D | 22.25 | 4,500 | 100,125 | 500 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | Corp. VP-Indus Pres ... | Option Exercise | A | 4.89 | 3,375 | 16,504 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | Corp. VP-Indus Pres ... | Option Exercise | D | 3.45 | 3,375 | 11,644 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | A | 19.70 | 7,500 | 147,750 | 7,500 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | D | 16.79 | 7,500 | 125,925 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | A | 18.42 | 2,500 | 46,050 | 2,500 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | D | 17.85 | 2,500 | 44,625 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | A | 19.37 | 450 | 8,717 | 450 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | D | 12.64 | 450 | 5,688 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Hermelin David S | Vice President | Option Exercise | A | 27.78 | 10,000 | 277,800 | 50,000 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Hermelin David S | Vice President | Option Exercise | D | 27.50 | 10,000 | 275,000 | 40,000 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Hermelin David S | Vice President | Option Exercise | A | 27.78 | 40,000 | 1,111,200 | 50,000 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Hermelin David S | Vice President | Option Exercise | D | 27.50 | 40,000 | 1,100,000 | 10,000 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Chief Administratio ... | Option Exercise | A | 19.99 | 2,500 | 49,975 | 2,500 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Chief Administratio ... | Option Exercise | D | 16.79 | 2,500 | 41,975 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Chief Administratio ... | Option Exercise | A | 18.42 | 2,500 | 46,050 | 2,500 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Chief Administratio ... | Option Exercise | D | 17.85 | 2,500 | 44,625 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Chief Administratio ... | Option Exercise | A | 25.25 | 5,000 | 126,250 | 5,000 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Chief Administratio ... | Option Exercise | D | 25.23 | 5,000 | 126,150 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Option Exercise | A | 19.99 | 2,500 | 49,975 | 2,500 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Option Exercise | D | 16.79 | 2,500 | 41,975 | 0 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Option Exercise | A | 18.42 | 2,500 | 46,050 | 2,500 | |
Oct 15 2007 | KVA, KVB | K-V Pharmaceutical ... | SCHELLENGER NORMAN D | Director | Option Exercise | D | 17.85 | 2,500 | 44,625 | 0 | |
Aug 31 2007 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 35,302 | 0 | 1,212,284 | 1.2 M to 1.2 M (-2.83 %) |
Aug 17 2007 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Option Exercise | M | 4,451.00 | 5,530 | 24,614,030 | 0 | |
Aug 17 2007 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Option Exercise | M | 4,433.00 | 4,705 | 20,857,265 | 0 | |
Aug 17 2007 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Buy | M | 4.45 | 5,530 | 24,614 | 77,625 | 72.1 K to 77.6 K (+7.67 %) |
Aug 17 2007 | KVA, KVB | K-V Pharmaceutical ... | MITCHELL GERALD R | Vice President and ... | Buy | M | 4.43 | 4,705 | 20,857 | 37,605 | 32.9 K to 37.6 K (+14.30 %) |
Jul 11 2007 | KVA, KVB | K-V Pharmaceutical ... | BLESER RITA | Pres. - Pharmaceuti ... | Option Exercise | A | 27.24 | 25,000 | 681,000 | 25,000 | |
Jul 11 2007 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 3,505 | 0 | 1,308,060 | 1.3 M to 1.3 M (-0.27 %) |
May 15 2007 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Sell | J | 0.00 | 900 | 0 | 11,124 | 12 K to 11.1 K (-7.49 %) |
Jan 18 2007 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | Corp VP-Indus Prese ... | Option Exercise | M | 4.89 | 3,375 | 16,504 | 0 | |
Jan 18 2007 | KVA, KVB | K-V Pharmaceutical ... | ANDERSON MICHAEL SHANNON | Corp VP-Indus Prese ... | Buy | M | 4.89 | 3,375 | 16,504 | 48,100 | 44.7 K to 48.1 K (+7.55 %) |
Jan 03 2007 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Option Exercise | M | 4.89 | 4,250 | 20,783 | 0 | |
Jan 03 2007 | KVA, KVB | K-V Pharmaceutical ... | CHIBNALL RICHARD H | Vice President/Fina ... | Buy | M | 4.89 | 4,250 | 20,783 | 33,250 | 29 K to 33.3 K (+14.66 %) |
Dec 29 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Option Exercise | M | 10.21 | 500 | 5,106 | 9,800 | |
Dec 29 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Option Exercise | M | 10.01 | 500 | 5,003 | 9,800 | |
Dec 29 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Buy | M | 10.21 | 500 | 5,106 | 3,700 | 3.2 K to 3.7 K (+15.63 %) |
Dec 29 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Buy | M | 10.01 | 500 | 5,003 | 12,024 | 11.5 K to 12 K (+4.34 %) |
Dec 29 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Gift | G | 0.00 | 28,144 | 0 | 118,677 | 146.8 K to 118.7 K (-19.17 %) |
Dec 29 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Buy | J | 0.00 | 28,144 | 0 | 146,821 | 118.7 K to 146.8 K (+23.71 %) |
Dec 29 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Sell | J | 0.00 | 28,144 | 0 | 1,856,690 | 1.9 M to 1.9 M (-1.49 %) |
Oct 06 2006 | KVA, KVB | K-V Pharmaceutical ... | Killmer Jonathon E | Director | Option Exercise | A | 23.80 | 5,000 | 119,000 | 5,000 | |
Oct 06 2006 | KVA, KVB | K-V Pharmaceutical ... | CARLIE KEVIN S | Director | Option Exercise | A | 23.70 | 2,000 | 47,400 | 2,000 | |
Oct 06 2006 | KVA, KVB | K-V Pharmaceutical ... | Van Vliet David A | Chief Administratio ... | Option Exercise | A | 23.70 | 100,000 | 2,370,000 | 100,000 | |
Sep 29 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Gift | G | 0.00 | 607,470 | 0 | 2,637,085 | 2 M to 2.6 M (+29.93 %) |
Sep 29 2006 | KVA, KVB | K-V Pharmaceutical ... | HERMELIN MARC S | Chairman & CEO | Gift | G | 0.00 | 490,531 | 0 | 1,884,834 | 1.4 M to 1.9 M (+35.18 %) |
Sep 21 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Option Exercise | M | 10.21 | 500 | 5,106 | 10,300 | |
Sep 21 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Option Exercise | M | 10.01 | 500 | 5,003 | 10,300 | |
Sep 21 2006 | KVA, KVB | K-V Pharmaceutical ... | Moyerman Eric D | President, Pharmace ... | Buy | M | 10.21 | 500 | 5,106 | 3,200 | 2.7 K to 3.2 K (+18.52 %) |